News
5d
Onlymyhealth on MSNWhat Is the Main Cause of Myocardial Infarction? Doctor ExplainsWhat is the main cause of myocardial infarction A cardiologist explains how atherosclerosis and blood clots trigger heart ...
For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...
BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...
6d
Onlymyhealth on MSNMyocardial Infarction vs Heart Attack: Cardiologist Reveals the Key Differences and CausesConfused about the difference between a myocardial infarction and a heart attack Read ahead as an expert explains the causes symptoms and why acting fast is crucial for your heart health ...
The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...
In an exclusive chat with Deccan Chronicle, Kshemavana’s Chief Wellness Officer warns against drug abuse, nutraceutical ...
In STEMI-induced cardiogenic shock, a microaxial flow pump can unload the heart by reducing native cardiac output and ...
For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...
There is increased risk for incident myocardial infarction among adults aged 18 to 64 years with joint exposure to ozone and increased ambient temperature.
2d
HealthDay on MSNLiving in Marginalized Neighborhoods Linked to Adverse Outcomes in Acute MIFor younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...
Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to a study published ...
12d
HealthDay on MSNEmpagliflozin Has Kidney Protective Effects in Acute Myocardial InfarctionTotal adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results